FDA To Review Experimental Gene Therapy To Treat Childhood Blindness – WBUR
|
FDA To Review Experimental Gene Therapy To Treat Childhood Blindness
WBUR A panel of experts will advise the Federal and Drug Administration on Thursday on whether to approve Luxturna, a one-time shot that would repair a defective gene that causes inherited child blindness. If approved, it would be the first legal gene … |
